Segment disclosures

Company overview

LISATA THERAPEUTICS, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

5 dimension combinations 30 retained observations 16 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Neostem Inc

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=clbs:NeostemIncMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-3117939000 USD2016-03-16 · 00:00:42.000ZOpen filing evidence
2014-01-01 – 2014-09-3012662000 USD2015-11-06 · 02:10:42.000ZOpen filing evidence
2014-04-01 – 2014-06-304489000 USD2015-08-07 · 01:02:04.000ZOpen filing evidence
2014-01-01 – 2014-06-308545000 USD2015-08-07 · 01:02:04.000ZOpen filing evidence
2013-01-01 – 2013-12-3114668000 USD2016-03-16 · 00:00:42.000ZOpen filing evidence

PCT Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=clbs:PCTSegmentMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-03-317922700 USD2017-05-16 · 00:55:42.000ZOpen filing evidence
2016-01-01 – 2016-12-3135269800 USD2017-03-17 · 05:13:46.000ZOpen filing evidence
2016-01-01 – 2016-03-317489500 USD2017-05-16 · 00:55:42.000ZOpen filing evidence
2015-01-01 – 2015-12-3122333100 USD2017-03-17 · 05:13:46.000ZOpen filing evidence

RD Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=clbs:RDSegmentMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-03-310 USD2017-05-16 · 00:55:42.000ZOpen filing evidence
2016-01-01 – 2016-12-3114000 USD2017-03-17 · 05:13:46.000ZOpen filing evidence
2016-01-01 – 2016-03-310 USD2017-05-16 · 00:55:42.000ZOpen filing evidence
2015-01-01 – 2015-12-31154400 USD2017-03-17 · 05:13:46.000ZOpen filing evidence

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=lsta:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD2026-08-07 · 00:03:41.000ZOpen filing evidence
2026-01-01 – 2026-06-300 USD2026-08-07 · 00:03:41.000ZOpen filing evidence
2025-01-01 – 2025-12-31170000 USD2026-03-13 · 00:07:03.000ZOpen filing evidence
2025-04-01 – 2025-06-3070000 USD2026-08-07 · 00:03:41.000ZOpen filing evidence
2025-01-01 – 2025-06-3070000 USD2026-08-07 · 00:03:41.000ZOpen filing evidence
2024-01-01 – 2024-12-311000000 USD2026-03-13 · 00:07:03.000ZOpen filing evidence
2023-01-01 – 2023-12-310 USD2025-02-28 · 02:10:54.000ZOpen filing evidence

Neostem Inc

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=nbs:NeostemIncMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-3117939000 USD2015-03-03 · 02:02:10.000ZOpen filing evidence
2014-01-01 – 2014-09-3012662000 USD2014-10-31 · 00:07:06.000ZOpen filing evidence
2014-04-01 – 2014-06-304489000 USD2014-08-08 · 00:06:17.000ZOpen filing evidence
2014-01-01 – 2014-06-308545000 USD2014-08-08 · 00:06:17.000ZOpen filing evidence
2014-01-01 – 2014-03-314056000 USD2015-05-06 · 02:13:19.000ZOpen filing evidence
2013-01-01 – 2013-12-3114668000 USD2015-03-03 · 02:02:10.000ZOpen filing evidence
2013-07-01 – 2013-09-303707000 USD2014-10-31 · 00:07:06.000ZOpen filing evidence
2013-01-01 – 2013-09-3010590000 USD2014-10-31 · 00:07:06.000ZOpen filing evidence
2013-04-01 – 2013-06-304359000 USD2014-08-08 · 00:06:17.000ZOpen filing evidence
2013-01-01 – 2013-06-306883000 USD2014-08-08 · 00:06:17.000ZOpen filing evidence